Why You Can Have Normal Haemoglobin but Low Iron Stores
A normal haemoglobin result does not necessarily mean the body has adequate iron stores. Iron deficiency can develop before haemoglobin falls into the anaemia range, which means a routine blood count may not tell the whole story when persistent tiredness has no obvious explanation.
That distinction has received fresh attention after the American Society of Hematology (ASH) issued new 2026 clinical practice guidelines on diagnosing iron deficiency, recommending higher ferritin thresholds for several groups and explicitly addressing iron deficiency with and without anaemia. The guidance was published on Sept. 16, 2026, in Blood Advances.
Haemoglobin and ferritin measure different things
Haemoglobin is the protein in red blood cells responsible for carrying oxygen. Ferritin, meanwhile, is a major marker of the body’s stored iron.
Iron deficiency can progress in stages. According to the U.S. National Institutes of Health’s Office of Dietary Supplements, iron stores may become depleted first, followed by changes in red blood cell production and eventually iron-deficiency anaemia. During the earlier stage, haemoglobin can remain within the normal range.
That is why someone can receive a reassuring haemoglobin result while still having insufficient iron stores.
The American Society of Hematology’s new guidelines are particularly relevant because they recommend diagnosing iron deficiency based on ferritin thresholds that are higher than some older cutoffs. For adults who are not menstruating or pregnant, ASH suggests a ferritin threshold of 30 ng/mL or lower, rather than the older 15 ng/mL threshold. For people with symptoms associated with iron deficiency or continuing risk factors, a threshold of 50 ng/mL or lower may be appropriate.
Why fatigue can appear before anaemia
Iron is not used only to make haemoglobin. It also plays roles in muscle metabolism, cellular function and neurological processes. The NIH notes that iron deficiency can affect physical performance, concentration and energy-related functions.
Clinical research has also found a relationship between low iron stores and fatigue in some people who do not have anaemia.
A randomized, double-blind BMJ trial involving 144 women aged 18 to 55 with unexplained fatigue found that those receiving oral iron experienced a greater reduction in fatigue after four weeks than those receiving placebo. The researchers found the apparent benefit was concentrated among participants whose ferritin was 50 µg/L or lower.
The study was relatively small and focused on women of childbearing age, so its findings should not be applied automatically to everyone with tiredness. Still, it provides evidence that fatigue and iron depletion can occur together even when haemoglobin is not low.
More recent research has continued to examine the issue. A 2025 randomized trial reported that intravenous iron improved fatigue scores after four weeks in recreationally active, iron-deficient, non-anaemic women, although the response varied considerably between individuals.
A “normal” ferritin result may not always settle the question
Ferritin is useful, but it is not a standalone test that can be interpreted identically in every situation.
Inflammation can raise ferritin levels, potentially making iron stores appear better than they actually are. The WHO recommends taking inflammation into account when interpreting ferritin, while ASH’s 2026 guidance recommends using both ferritin and transferrin saturation in adults with inflammation.
Under the new ASH guidance, iron deficiency in adults with inflammation may be considered when ferritin is below 100 ng/mL or transferrin saturation is below 20%. The guideline specifically covers conditions in which inflammation can complicate interpretation, including cancer, inflammatory bowel disease and infectious disease.
A high ferritin level, therefore, does not automatically mean iron stores are excessive. Inflammation, infection, liver disease and several other conditions can increase ferritin.
What the new guidance changes
Jacquelyn M. Powers, MD, MS, chair of the ASH guideline panel, said the updated thresholds were intended to address longstanding inconsistency in how iron deficiency is diagnosed.
“These updated ferritin thresholds provide clear guidance in an area where consensus has been lacking,” Powers said in an ASH statement.
The recommendations differ according to the population.
For adults, menstruating individuals and pregnant individuals, ASH recommends a ferritin threshold of 30 ng/mL or lower for diagnosing iron deficiency. A threshold of 50 ng/mL or lower can be considered in higher-risk situations, including heavy menstrual bleeding and, in certain circumstances, pregnancy.
The guideline also emphasizes that diagnosis should not depend solely on whether a person has anaemia.
Why someone might become iron deficient
Low iron stores can have several causes. Blood loss is one of the most important causes, including heavy menstrual bleeding. Other possibilities include inadequate dietary intake, increased requirements such as during pregnancy, problems absorbing iron, and certain gastrointestinal conditions.
The reason behind the deficiency matters. Simply identifying a low ferritin result without investigating why iron stores are depleted may leave the underlying problem untreated.
Persistent fatigue can also have many causes unrelated to iron, including inadequate sleep, thyroid disorders, diabetes, sleep apnoea and other medical conditions. The NHS advises people not to self-diagnose persistent tiredness.
Should you take iron if you’re tired?
Not automatically.
Iron supplements can be useful when iron deficiency has been established, but taking iron without knowing whether it is needed is not risk-free. High supplemental doses can cause nausea, constipation, abdominal discomfort and other gastrointestinal effects, while excessive iron exposure can be harmful. The NIH lists a tolerable upper intake level of 45 mg per day for adults, although clinicians may prescribe higher doses for specific medical reasons.
The more useful question for someone with persistent unexplained fatigue may therefore be whether iron status has been adequately assessed rather than whether haemoglobin alone is normal.
A clinician may consider ferritin alongside the complete blood count and, depending on the circumstances, transferrin saturation and markers of inflammation. The appropriate tests and interpretation depend on a person’s age, sex, pregnancy status, symptoms, medical history and potential sources of blood loss.
The key point is straightforward: normal haemoglobin and adequate iron stores are not the same thing. A haemoglobin result can look reassuring while iron reserves are already depleted. The new ASH guidance gives clinicians more specific thresholds for recognizing that situation, although further investigation is still needed to determine why iron is low and whether treatment is appropriate.
